EU Geothermal Plan and Lionheart Funding Underpin Vulcan Energy Amid Mild Share Dilution

Vulcan Energy’s stock has been walking a tightrope in recent days. After a weekly advance of 5% that pushed shares comfortably above their 50-day moving average, the stock slipped 4.7% to €2.40 on Wednesday — a reaction to a routine but notable administrative move: the conversion of performance rights into ordinary equity. The dip, however, barely scratches the surface of a far larger story unfolding across Brussels and the Oberrheingraben.

The company’s flagship Lionheart project remains the centrepiece of investor attention. Located in the Upper Rhine Valley straddling Germany and France, the integrated geothermal and lithium operation secured financial close on 28 May 2026, locking in a €2.2 billion funding package that combines debt and equity. Lionheart targets first-phase production of 24,000 tonnes of lithium hydroxide monohydrate per year, alongside 275 gigawatt-hours of renewable electricity and 560 GWh of heat annually, with a projected mine life of three decades.

On the policy front, Vulcan’s chief commercial officer, Manfred Boeckman, took the stage at the European Geothermal Summit in Brussels this week. The summit’s core agenda revolved around the European Commission’s planned Geothermal Action Plan, set for implementation from May 2026. Brussels is preparing to roll out EU-wide geological databases and state-backed insurance mechanisms designed to mitigate the exploration risk that burdens capital-intensive deep drilling. For Vulcan, these instruments could materially improve the economics of Lionheart’s drilling programme and accelerate the permitting process.

Should investors sell immediately? Or is it worth buying Vulcan Energy?

The share issuance that rattled the market on Wednesday is, by contrast, a minor operational footnote. Vulcan applied for quotation of 757,423 new fully paid ordinary shares on 1 June, stemming from the conversion of performance rights granted under employee incentive schemes. The estimated value per right was set at A$4.155, and no new capital was raised. The dilution amounts to roughly 0.16% of the enlarged share capital, which now stands at 478,660,737 shares. A total of 2,510,165 performance rights remain outstanding.

Among the beneficiaries were three senior executives: Cris Moreno converted 137,459 rights, Dr. Francis Wedin 9,724 and Dr. Guenter Hilken 4,746 — together accounting for about 20% of the newly listed shares. As Vulcan confirmed in its Australian and German regulatory filings, the issuance complied with the Corporations Act and required no prospectus, making it a pure compliance event rather than a signal of operational change.

Despite the midweek drop, the stock still trades well above its March 2026 trough of €1.77. The market’s verdict on Vulcan now hinges less on minor administrative adjustments and more on whether the company can translate Lionheart’s €2.2 billion bankroll, along with the incubating EU policy support, into tangible construction milestones. The next few months will test whether the pledges made in Brussels can crystallise into bankable tools for the build-out phase — and whether that translates into sustained upward momentum for the shares.

Ad

Vulcan Energy Stock: New Analysis - 4 June

Fresh Vulcan Energy information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Vulcan Energy analysis...

en | AU0000066086 | GEOTHERMAL | boerse | 69479958 |